Best Stock Screeners in 2026
Tools for turning nine thousand tickers into a shortlist you can actually research.
The best stock screeners in 2026 are TradingView for charting plus screening in one place, Finviz for the fastest free visual screen, Stock Rover for deep fundamental and portfolio analysis, Koyfin for institutional-grade data at a retail price, and Zacks if you want ranked estimate revisions rather than raw filters. Start free: three of these are genuinely usable at zero cost.
This is a comparison of research tools, not investment advice. Nothing here is a recommendation to buy or sell any security.
Key facts5 tools compared: TradingView, Finviz, Stock Rover, Koyfin, Zacks
- 5 tools compared: TradingView, Finviz, Stock Rover, Koyfin, Zacks
- Finviz (best for: The fastest free screen on US equities): Free tier with delayed data; Elite $39.50/mo or $299.95/yr
- Stock Rover (best for: Deep fundamental analysis and portfolio work): Free tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trial
- Koyfin (best for: Institutional-style data on a retail budget): Free tier; Plus $39/mo, Premium $79/mo; annual billing saves up to 30%
A screener does one job: reduce a universe of thousands of listed companies to a handful worth reading about. Everything after that is your work. The tools differ on which filters they expose, how far back the data goes, whether you can test an idea historically, and how much of it survives on the free tier. Pick based on whether you think in charts, in financial statements, or in estimate revisions.
Research tooling comparison only. This is not investment advice and none of these tools should be treated as a recommendation.
Top Picks
Based on features, real-world fit, and value for money.
The most-used charting platform on the internet, with a capable screener attached and the largest community of shared indicators.
From $12.95/mo billed annually (Essential); free plan ($0)
Investors who want screening and charting in one tool
The screener most people start with: dozens of filters, instant results, and a heat map that shows the whole market at a glance.
Free tier with delayed data; Elite $39.50/mo or $299.95/yr
The fastest free screen on US equities
The fundamentals specialist: hundreds of metrics, a decade of history, and portfolio analytics that connect screening to what you already own.
Free tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trial
Deep fundamental analysis and portfolio work
| Tool | Pricing | Best for |
|---|---|---|
| TradingView | From $12.95/mo billed annually (Essential); free plan ($0) | Investors who want screening and charting in one tool |
| Finviz | Free tier with delayed data; Elite $39.50/mo or $299.95/yr | The fastest free screen on US equities |
| Stock Rover | Free tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trial | Deep fundamental analysis and portfolio work |
| Koyfin | Free tier; Plus $39/mo, Premium $79/mo; annual billing saves up to 30% | Institutional-style data on a retail budget |
| Zacks | Free tools; Premium and higher plans, check current pricing | Screening on analyst estimate revisions |
Pricing read from each vendor's own pricing page, checked Sep 2026. 1 of 5 publishes prices for some plans and quotes the rest.
TradingView
The most-used charting platform on the internet, with a capable screener attached and the largest community of shared indicators.
- Pricing
- From $12.95/mo billed annually (Essential); free plan ($0)
Best for: Investors who want screening and charting in one tool
Pros
- Charting is best in class and the screener sits right beside it
- Genuinely usable free tier, and Essential at $12.95 removes most friction
- Huge library of community indicators and screening scripts
Cons
- Fundamental data is thinner than the dedicated fundamental screeners
- Free tier caps you at 2 indicators per chart and 3 price alerts
Finviz
The screener most people start with: dozens of filters, instant results, and a heat map that shows the whole market at a glance.
- Pricing
- Free tier with delayed data; Elite $39.50/mo or $299.95/yr
Best for: The fastest free screen on US equities
Pros
- Free tier is remarkably capable, with around 70 filters on US stocks
- Fastest interface here, results appear as you set filters
- The market heat map is the best quick read of sector rotation anywhere
Cons
- Free data is delayed, which rules it out for anything time-sensitive
- US-focused, with weak international coverage
Stock Rover
The fundamentals specialist: hundreds of metrics, a decade of history, and portfolio analytics that connect screening to what you already own.
- Pricing
- Free tier; Premium $29/mo, Premium Plus $49/mo, Ultimate $79/mo; 14-day trial
Best for: Deep fundamental analysis and portfolio work
Pros
- Deepest fundamental dataset here, with up to 10 years of history on higher tiers
- Screening, portfolio tracking and rebalancing in one place
- Excellent research reports and peer comparison tables
Cons
- Interface is dense and dated compared with TradingView
- Charting is functional rather than good
Koyfin
The closest thing to a Bloomberg terminal at consumer pricing, with global coverage and excellent macro data alongside equities.
- Pricing
- Free tier; Plus $39/mo, Premium $79/mo; annual billing saves up to 30%
Best for: Institutional-style data on a retail budget
Pros
- Data breadth and presentation feel professional rather than retail
- Strong global coverage including European and Asian listings
- Macro, credit and FX data alongside equities in one dashboard
Cons
- Screener is good but not the deepest here for fundamentals
- Learning curve is real if you have not used a terminal before
Zacks
Built around the Zacks Rank, which sorts companies by earnings estimate revisions rather than raw financial filters.
- Pricing
- Free tools; Premium and higher plans, check current pricing
Best for: Screening on analyst estimate revisions
Pros
- Estimate revision data is its genuine differentiator and hard to get elsewhere at this price
- The Rank gives a starting shortlist without building a screen yourself
- Long track record and extensive published research
Cons
- Heavily oriented to one methodology, which you have to buy into
- Site design is cluttered and pushes upsells constantly
What it is
A stock screener filters a universe of securities against criteria you define: valuation multiples, growth rates, margins, technical conditions, ownership, or analyst estimates. Modern screeners layer on charting, backtesting (would this filter have produced anything historically), portfolio integration and alerting. The good ones let you save a screen and get notified when a new name qualifies rather than re-running it manually.
Why it matters
Without a screener you research the companies you happen to hear about, which is a well-documented way to end up owning whatever was in the news. A screen imposes a repeatable, explicit process: you write down what you are looking for, and the tool tells you which companies meet it. The discipline matters more than the software. The best screener is the one whose filters match how you actually think about a business.
Key features to look for
Pricing
TradingView, Finviz, Stock Rover and Koyfin all publish rate cards, checked on each vendor's pricing page in September 2026, while Zacks keeps its paid research behind named plans. TradingView lists a free plan, then Essential, Plus, Premium and Ultimate at a per-month rate billed annually.
Finviz Elite is $39.50 a month or $299.95 a year, Stock Rover Premium starts at $29 a month with a 14-day trial, and Koyfin Plus is $39 a month. No tool in this category is sold only on a custom quote. The cheapest credible entry is a free plan, and TradingView Essential is the lowest published paid price.
Costs jump at TradingView Ultimate and Stock Rover's Ultimate tiers, and Finviz's free tier carries delayed data, so Elite is the paid step when you need current quotes.
| Plan | Price | Best for |
|---|---|---|
| TradingView Free | $0 | 1 chart per tab, 2 indicators per chart, 3 price alerts |
| TradingView Essential | $12.95/mo billed annually | Entry paid plan, annual savings |
| TradingView Plus | $29.95/mo billed annually | Paid plan, annual savings |
| TradingView Premium | $59.95/mo billed annually | Paid plan, annual savings |
| TradingView Ultimate | $199.95/mo billed annually | Highest listed plan, billed annually |
| Finviz Free | Free | Free tier with delayed data |
| Finviz Elite | $39.50/mo or $299.95/yr | Real-time quotes, backtesting and unlimited alerts |
| Stock Rover Premium | $29/mo | Entry paid plan above the free tier, 14-day trial |
| Stock Rover Premium Plus | $49/mo | Deeper research data and screening |
| Stock Rover Ultimate | $79/mo | Top individual plan; Ultimate Pro is $149/mo |
| Koyfin Plus | $39/mo | 10 years of financials and stock screeners |
| Koyfin Premium | $79/mo | Adds portfolio analytics and custom formulas |
| Zacks Premium | Check current pricing | Paid research subscription |
| Zacks higher research | Check current pricing | Higher research subscriptions |
The bottom line
If you think in charts, start with TradingView, and its free tier plus Essential at $12.95 a month billed annually covers most retail needs. If you think in financial statements, Stock Rover has the deepest data. Finviz remains the fastest free screen on US equities and is worth keeping open regardless of what else you use, while Koyfin is the pick for global coverage. Whichever you choose, the screener is the cheap part; the research after it is the work.
Comparison of research tools only, not investment advice.
Frequently asked questions
What is the best free stock screener?
How much does a stock screener cost?
Is TradingView good for fundamental screening?
Can stock screeners backtest strategies?
Sources
Prices and plan details come from each vendor's own pricing page, re-checked by the Toolradar pricing tracker.
- TradingView pricingchecked Sep 2026
- Finviz pricingchecked Sep 2026
- Stock Rover pricingchecked Sep 2026
- Koyfin pricingchecked Sep 2026
- Zacks pricingchecked Sep 2026
Some offers on this page may be paid placements or contain affiliate links.
Get the Finpresso brief
Free daily newsletter, read in 5 minutes.
Subscribe free